<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00904150</url>
  </required_header>
  <id_info>
    <org_study_id>COLMC-GEN-2007</org_study_id>
    <secondary_id>REC Ref: 07/H0703/107</secondary_id>
    <secondary_id>Proposal # 36470</secondary_id>
    <secondary_id>Grant Application 2007/03</secondary_id>
    <nct_id>NCT00904150</nct_id>
  </id_info>
  <brief_title>Study of the Molecular Genetics of Menstrual Migraine</brief_title>
  <official_title>A Case-control Study of the Molecular Genetics of Menstrual Migraine (Pure Menstrual and Menstrually-related Migraine)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The City of London Migraine Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Griffith University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The City of London Migraine Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that genes that play a role in menstrual migraine can be
      identified using a well characterised migraine population and a comprehensive genome-wide
      association scan approach.

      The aim of the study is to identify genes, genetic regions, and the effect of hormones on
      expression profiles in women with menstrual migraine compared to a control population with no
      personal or first-degree family history of migraine.

      In this case control study, saliva samples will be taken from 300 cases and 300 controls for
      DNA analysis. Blood samples from 30 cases and 30 controls will be taken during the follicular
      phase as well as the luteal phase of the menstrual cycle for ribonucleic acid (RNA) analysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progesterone Receptor Gene Polymorphism PROGINS in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>PR PROGINS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estrogen Receptor 1 G594a Polymorphism in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>ESR1 G594A</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estrogen Receptor 1 C325G Polymorphism in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>ESR1 C325G</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Menstrual Cycle Expression of PGR and ESR in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>PgR and ESR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumour Necrosis Factor Genotype in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>TNF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SYNE1 Genotype in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>SYNE1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menstrual Cycle Expression of TNF and SYNE1 in Women With Menstrual Migraine and Women Without Migraine</measure>
    <time_frame>6 years</time_frame>
    <description>TNF and SYNE1</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">585</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>1 Menstrual migraine</arm_group_label>
    <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 No migraine</arm_group_label>
    <description>Caucasian women with no personal history of migraine</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva Whole Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Caucasian women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All cases and controls must:

          -  Be over 18 years

          -  Caucasian

          -  Provide written, informed consent

          -  Clearly understand and be able to comply with all the trial procedures, as required

          -  Not have taken part in trials of any investigational products within the previous 4
             weeks

        DNA Study:

          -  Cases must have at least a 12-month current or past history of menstrual migraine

        RNA Study:

          -  Cases must have at least a 12-month current history of menstrual migraine

          -  Cases must have kept at least three months of headache diary data in advance of visit
             in order to confirm diagnosis

          -  Controls must still be having menstrual periods

        Exclusion Criteria:

        DNA Study:

          -  Cases and controls must not have smoked, chewed gum or consumed any food or drink in
             the 30 minutes prior to sample collection

        RNA Study:

          -  Cases and controls will not be eligible for participation if they have:

               -  Polycystic ovarian syndrome;

               -  Taken any hormones or drugs in the previous three months that may affect normal
                  hormone activity (e.g., hormonal contraceptives, hormone replacement therapy,
                  dietary supplements such as isoflavones);

               -  Donated or lost a significant amount of blood (&gt; 550 mL) within the previous 12
                  weeks

               -  Additionally, controls must not have a personal or family history in any
                  first-degree relative of current or past migraine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>E A MacGregor, FFSRH MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Neuroscience and Trauma, Queen Mary, University of London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lyn Griffiths, BSc(Hons) PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Genomics Research Centre Griffith University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The City of London Migraine Clinic</name>
      <address>
        <city>London</city>
        <zip>EC1M 6DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2009</study_first_submitted>
  <study_first_submitted_qc>May 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2009</study_first_posted>
  <results_first_submitted>September 8, 2013</results_first_submitted>
  <results_first_submitted_qc>February 18, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 24, 2014</results_first_posted>
  <last_update_submitted>February 18, 2014</last_update_submitted>
  <last_update_submitted_qc>February 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Mary University of London</investigator_affiliation>
    <investigator_full_name>Dr E Anne MacGregor</investigator_full_name>
    <investigator_title>Professor E Anne MacGregor</investigator_title>
  </responsible_party>
  <keyword>menstruation</keyword>
  <keyword>migraine</keyword>
  <keyword>menstrual migraine</keyword>
  <keyword>genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Premenstrual Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>1 Menstrual Migraine</title>
          <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
        </group>
        <group group_id="P2">
          <title>2 No Migraine</title>
          <description>Caucasian women with no personal history of migraine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Saliva Samples (DNA)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="285"/>
                <participants group_id="P2" count="300"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="282"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="145"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>saliva samples not suitable for assay</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Australian samples of different genotype</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="145"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Blood Samples (RNA): Follicular Phase</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Blood Samples (RNA): Luteal Phase</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 Menstrual Migraine</title>
          <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
        </group>
        <group group_id="B2">
          <title>2 No Migraine</title>
          <description>Caucasian women with no personal history of migraine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="285"/>
            <count group_id="B2" value="300"/>
            <count group_id="B3" value="585"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="285"/>
                    <measurement group_id="B2" value="300"/>
                    <measurement group_id="B3" value="585"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="285"/>
                    <measurement group_id="B2" value="300"/>
                    <measurement group_id="B3" value="585"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="285"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="440"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Progesterone Receptor Gene Polymorphism PROGINS in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>PR PROGINS</description>
        <time_frame>6 years</time_frame>
        <population>Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Progesterone Receptor Gene Polymorphism PROGINS in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>PR PROGINS</description>
          <population>Not all samples were suitable for analysis for each outcome measure</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="153"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No PROGINS insert</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="208"/>
                    <measurement group_id="O2" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heterozygote</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Homozygote</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Statistical analysis is of the distribution of PR PROGINS polymorphism frequencies between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.513</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estrogen Receptor 1 G594a Polymorphism in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>ESR1 G594A</description>
        <time_frame>6 years</time_frame>
        <population>Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Estrogen Receptor 1 G594a Polymorphism in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>ESR1 G594A</description>
          <population>Not all samples were suitable for analysis for each outcome measure</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Genotype GG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="196"/>
                    <measurement group_id="O2" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype GA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype AA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Statistical analysis is of the distribution of Estrogen receptor 1 G594a polymorphism frequencies between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tumour Necrosis Factor Genotype in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>TNF</description>
        <time_frame>6 years</time_frame>
        <population>Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Tumour Necrosis Factor Genotype in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>TNF</description>
          <population>Not all samples were suitable for analysis for each outcome measure</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="190"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Genotype GG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype GA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype AA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis of distribution of TNF genotype frequencies between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002743</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.434</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.24</ci_lower_limit>
            <ci_upper_limit>0.75</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SYNE1 Genotype in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>SYNE1</description>
        <time_frame>6 years</time_frame>
        <population>Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>SYNE1 Genotype in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>SYNE1</description>
          <population>Not all samples were suitable for analysis for each outcome measure</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="215"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Genotype TT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype TG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype GG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis of distribution of SYNE1 genotype frequencies between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02462</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.69</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.49</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estrogen Receptor 1 C325G Polymorphism in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>ESR1 C325G</description>
        <time_frame>6 years</time_frame>
        <population>Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Estrogen Receptor 1 C325G Polymorphism in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>ESR1 C325G</description>
          <population>Not all samples were suitable for analysis for each outcome measure</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Genotype CC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype CG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype GG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Statistical analysis is of the distribution of Estrogen receptor 1 C325G polymorphism frequencies between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.18</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Menstrual Cycle Expression of PGR and ESR in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>PgR and ESR</description>
        <time_frame>6 years</time_frame>
        <population>Matched pairs of follicular and luteal samples Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Menstrual Cycle Expression of PGR and ESR in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>PgR and ESR</description>
          <population>Matched pairs of follicular and luteal samples Not all samples were suitable for analysis for each outcome measure</population>
          <units>number of genes expressed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ESR expression in follicular phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.98">Data not reported</measurement>
                    <measurement group_id="O2" value="16.73">Data not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ESR expression in luteal phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.58">Data not reported</measurement>
                    <measurement group_id="O2" value="15.62">Data not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PGR expression in follicular phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.62">Data not reported</measurement>
                    <measurement group_id="O2" value="9.80">Data not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PGR expression in luteal phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.95">Data not reported</measurement>
                    <measurement group_id="O2" value="8.69">Data not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Menstrual Cycle Expression of TNF and SYNE1 in Women With Menstrual Migraine and Women Without Migraine</title>
        <description>TNF and SYNE1</description>
        <time_frame>6 years</time_frame>
        <population>Matched luteal and follicular phase samples Not all samples were suitable for analysis for each outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>1 Menstrual Migraine</title>
            <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
          </group>
          <group group_id="O2">
            <title>2 No Migraine</title>
            <description>Caucasian women with no personal history of migraine</description>
          </group>
        </group_list>
        <measure>
          <title>Menstrual Cycle Expression of TNF and SYNE1 in Women With Menstrual Migraine and Women Without Migraine</title>
          <description>TNF and SYNE1</description>
          <population>Matched luteal and follicular phase samples Not all samples were suitable for analysis for each outcome measure</population>
          <units>number of genes expressed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TNF expression in follicular phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.16">Not reported</measurement>
                    <measurement group_id="O2" value="17.33">Not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNF expression in luteal phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.24">Not reported</measurement>
                    <measurement group_id="O2" value="16.96">Not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SYNE1 expression in follicular phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.56">Not reported</measurement>
                    <measurement group_id="O2" value="20.68">Not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SYNE1 expression in luteal phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.01">Not reported</measurement>
                    <measurement group_id="O2" value="20.06">Not reported</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>This is not an interventional study so serious and another [non-serious] adverse events could not be assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>1 Menstrual Migraine</title>
          <description>Caucasian women with a current or past history of menstrual migraine (MM = pure menstrual migraine or menstrually-related migraine) attending the City of London Migraine Clinic</description>
        </group>
        <group group_id="E2">
          <title>2 No Migraine</title>
          <description>Caucasian women with no personal history of migraine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Anne MacGregor</name_or_title>
      <organization>Centre for Neuroscience and Trauma, Queen Mary, University of London</organization>
      <phone>+44 7774 868628</phone>
      <email>e.macgregor@qmul.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

